Voloridge Investment Management, LLC Anavex Life Sciences Corp. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $2.54 Million - $3.51 Million	-150,710 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $569,003 - $871,096	-33,829 Reduced 18.33%	150,710 $2.71 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $1.87 Million - $5.33 Million	184,539 New	184,539 $4.22 Million
Q1 2021 May 17, 2021	SELL	$5.17 - $16.13 $216,886 - $676,669	-41,951 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $168,223 - $317,988	41,951 New	41,951 $227,000

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.